X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1273) 1273
Publication (112) 112
Book Review (33) 33
Book Chapter (7) 7
Conference Proceeding (4) 4
Data Set (1) 1
Dissertation (1) 1
Magazine Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (686) 686
animals (663) 663
pharmacology & pharmacy (438) 438
oligonucleotides, antisense - pharmacology (347) 347
biochemistry & molecular biology (345) 345
mice (328) 328
index medicus (325) 325
antisense oligonucleotides (274) 274
phosphorothioate (265) 265
oligonucleotides (253) 253
phosphorothioate oligodeoxynucleotides (245) 245
base sequence (244) 244
phosphorothioate oligonucleotides (232) 232
male (211) 211
inhibition (182) 182
medicine, research & experimental (180) 180
oligodeoxynucleotides (180) 180
expression (172) 172
in-vivo (170) 170
antisense (161) 161
messenger-rna (151) 151
female (150) 150
molecular sequence data (149) 149
gene-expression (148) 148
rats (147) 147
dna (140) 140
oligonucleotides, antisense - chemistry (140) 140
cells (134) 134
rna (132) 132
thionucleotides - pharmacology (130) 130
biotechnology & applied microbiology (127) 127
cell line (125) 125
chemistry, medicinal (124) 124
oligonucleotides, antisense - pharmacokinetics (124) 124
pharmacokinetics (124) 124
phosphorothioate oligonucleotide (109) 109
in-vitro (105) 105
oligodeoxyribonucleotides - pharmacology (104) 104
oligonucleotides, antisense - therapeutic use (103) 103
immunology (102) 102
oncology (102) 102
dose-response relationship, drug (97) 97
cells, cultured (94) 94
oligonucleotides, antisense - administration & dosage (92) 92
rna, messenger - genetics (91) 91
tumor cells, cultured (87) 87
structure-activity relationship (86) 86
oligonucleotides, antisense - genetics (85) 85
bacterial-dna (83) 83
human-immunodeficiency-virus (83) 83
rna, messenger - metabolism (83) 83
gene expression (81) 81
oligonucleotides, antisense - metabolism (81) 81
oligonucleotide (80) 80
phosphorothioate oligonucleotides - pharmacology (76) 76
stability (76) 76
activation (74) 74
oligonucleotides - pharmacology (71) 71
antisense oligonucleotide (68) 68
cellular uptake (68) 68
antiviral agents - pharmacology (67) 67
delivery (66) 66
drug design (66) 66
oligonucleotides - chemistry (66) 66
cancer (64) 64
cell biology (64) 64
gene (64) 64
oligodeoxyribonucleotides, antisense - pharmacology (64) 64
binding (63) 63
transfection (63) 63
kinetics (61) 61
mice, inbred balb c (61) 61
research (61) 61
cell line, tumor (60) 60
phosphorothioate oligodeoxynucleotide (60) 60
replication (60) 60
analysis (59) 59
cell division - drug effects (59) 59
proteins (58) 58
chemistry, multidisciplinary (57) 57
nucleic acid conformation (57) 57
liposomes (56) 56
oligodeoxyribonucleotides - chemistry (56) 56
analogs (55) 55
apoptosis (55) 55
phosphorothioates (55) 55
tissue distribution (55) 55
antineoplastic agents - pharmacology (54) 54
rats, sprague-dawley (53) 53
virus replication - drug effects (53) 53
clinical trials as topic (52) 52
mice, inbred c57bl (50) 50
toxicology (50) 50
oligodeoxynucleotide (49) 49
pharmacology (49) 49
article (48) 48
toxicity (48) 48
thionucleotides - chemistry (47) 47
virology (47) 47
adjuvants, immunologic - pharmacology (46) 46
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nucleic Acid Therapeutics, ISSN 2159-3337, 02/2017, Volume 27, Issue 1, pp. 56 - 66
Journal Article
Journal Article
Clinical & Experimental Immunology, ISSN 0009-9104, 12/2007, Volume 150, Issue 3, pp. 576 - 584
Journal Article
Journal Article
Methods, ISSN 1046-2023, 2008, Volume 44, Issue 1, pp. 55 - 60
Journal Article
Nature, ISSN 0028-0836, 08/2012, Volume 488, Issue 7409, pp. 111 - 115
Antisense oligonucleotides (ASOs) hold promise for gene-specific knockdown in diseases that involve RNA or protein gain-of-function effects. In the hereditary... 
CTG REPEAT | 3' END | PROTEIN | MESSENGER-RNA | MULTIDISCIPLINARY SCIENCES | GENE-EXPRESSION | TOXIC RNA | MODIFIED ANTISENSE OLIGONUCLEOTIDE | PHOSPHOROTHIOATE OLIGONUCLEOTIDES | MOUSE MODELS | TRINUCLEOTIDE REPEAT | Humans | Muscle, Skeletal - metabolism | RNA, Messenger - metabolism | RNA, Untranslated - genetics | Gene Knockdown Techniques | RNA - genetics | Myotonic Dystrophy - pathology | Base Sequence | Muscle, Skeletal - drug effects | Oligonucleotides, Antisense - therapeutic use | RNA, Messenger - antagonists & inhibitors | Mice, Inbred mdx | Myotonic Dystrophy - genetics | Disease Models, Animal | RNA - metabolism | Oligonucleotides, Antisense - pharmacology | Myotonin-Protein Kinase | RNA - antagonists & inhibitors | Mice, Inbred C57BL | RNA, Messenger - genetics | Gene Silencing | Protein-Serine-Threonine Kinases - genetics | Mice, Transgenic | Myotonic Dystrophy - therapy | Transcriptome - drug effects | Transcriptome - genetics | Myotonic Dystrophy - physiopathology | Animals | Oligonucleotides, Antisense - genetics | Cell Nucleus - genetics | RNA, Long Noncoding | Alleles | Trinucleotide Repeat Expansion - genetics | Mice | Mice, Inbred BALB C | Cell Nucleus - drug effects | Ribonuclease H - metabolism | Myotonic dystrophy | RNA | Oligonucleotides | Physiological aspects | Development and progression | Genetic aspects | Health aspects
Journal Article
Journal Article